Old funding and research methods are no longer working for small biotechs, big pharma or academic scientists. The flip side of this crisis is breeding innovation at every stage of the drug discovery pipeline. As […]
The second day of BIO 2014 International Convention, Tuesday June 24th, presented at least two opportunities to learn about biosimilars, which haven’t only been gaining momentum from research and development over the last several years, […]
BIO 2014: Innovations in 3-D Tissue for Disease and Drug Discovery | Xconomy.
A NEW BIO Convention forum on Digital Health was added to this year’s agenda. Throughout the day on Tuesday, it attracted hundreds of attendees and was a tsunami of engaging discussions, meetings, Q&A and interviews. […]
Traditionally, BIO has been focused on bringing well-established biotech and pharma companies together. This year, the organizers wanted to shake things up abit and allow NIH/NSF funded SBIR companies, some of which have zero revenue, to showcase their business and have an opportunity […]
BIO 2014 biotech convention uses entertainment for business | UTSanDiego.com.
BIO 2014: Two Cities, One Economy, and a Unique Innovation Ecosystem | Xconomy.
It has been four decades since the initiation of President Nixon’s “War on Cancer”, but never have the signs for victory looked so encouraging. This is an exciting phase in cancer research, so much so […]
BIO 2014: Training Bio-Entrepreneurs to Use Coffee, Yoga, and Data | Xconomy.